ASGCT Annual Meeting 2026
Following the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting 2026, our Beacon RNA research team has analysed the most impactful data emerging across the field. This post conference report consolidates insights from the 94 RNA-relevant abstracts, highlighting key advances in clinical and preclinical programmes, evolving therapeutic approaches, and emerging delivery innovations shaping the next wave of therapeutics.
What’s inside the report:
A focused view of RNA‑relevant innovation
An analyst‑curated selection of 94 RNA‑relevant abstracts from ASGCT 2026. With coverage across clinical and preclinical programmes, screened for strategic relevance.
Built for smarter strategic planning
Gain a clear view of where the market is moving, from the dominance of preclinical innovation to the increasing focus on targeted delivery systems and next-generation modalities. Download the report to access detailed abstract analysis, curated summaries, and actionable insights to inform your strategic decision-making.
You May Also Be Interested In…
Learn More About RNA
- The Most Comprehensive Way to Search the RNA Drug Development Landscape: Unique search ontologies based on RNA drug and trial characteristics
- Market Leading Approach to RNA Preclinical & Clinical Data Curation: Manual curation of key RNA research and development data points by RNA research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search RNA company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
